Today, the US Food and Drug Administration (FDA) issued guidance on its intent to delay enforcement of the requirements for cosmetic product facility registration and cosmetic product listing requirements under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) for six months. The agency said the delay is designed to help ensure that industry has sufficient time to submit such facility registration and product listing information. FDA said it does not intend to enforce the requirem...